Mochi Health

Mochi Health's membership is one part of its advertised treatment pathway. The $79 monthly subscription covers the stated access model, while medicine and diagnostics are separate. An eligible first-month promotion does not remove those additional categories.

Keep the exact treatment visible

The homepage includes both branded and compounded options. It advertises compounded injectable semaglutide from $60 and tirzepatide from $90, with availability and pricing varying by state. A starting figure cannot identify the preparation a clinician would recommend or its eventual total cost.

Compounded medicines are not FDA-approved. Ask why an available approved option cannot meet the medical need and identify the dispensing pharmacy. This profile does not treat the range of advertised products as interchangeable treatment choices.

Connect membership support with other care

Mochi describes provider access, coaching and support. Ask how the treating professional receives your existing records and how changes are communicated to other clinicians. Our medication-list guide helps prepare that information.

Obtain the selected plan’s renewal and cancellation rules before accepting the introductory discount. An insurance-carrier selector does not establish a benefit decision. Confirm what is covered, what is cash-pay and which team is responsible for resolving a disputed or delayed claim.

Ask about a future change now

If the proposed medicine becomes unaffordable or the service arrangement changes, ask whom to contact before changing treatment yourself. The coverage-change guide follows that process. We have not tested Mochi's clinical coordination, pharmacy fulfillment or individual outcomes; the profile identifies the public model and its unresolved patient-specific details.